-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

Morgan Stanley Maintains Overweight on SI-BONE, Lowers Price Target to $18

Benzinga · 01/06/2023 10:22
Morgan Stanley analyst Drew Ranieri maintains SI-BONE (NASDAQ:SIBN) with a Overweight and lowers the price target from $21 to $18.